[Federal Register: April 4, 2005 (Volume 70, Number 63)]
[Notices]
[Page 17124]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr04ap05-132]

-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Registration

    By Notice dated December 21, 2004, and published in the Federal
Register on January 4, 2005, (70 FR 390), Cedarburg Pharmaceuticals,
Inc., 870 Badger Circle, Grafton, Wisconsin 53024, made application by
letter to the Drug Enforcement Administration (DEA) to be registered as
a bulk manufacturer of the basic classes of controlled substances
listed in Schedule II:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Dihydrocodeine (9120)......................  II
Remifentanil (9739)........................  II
Sufentanil (9740)..........................  II
------------------------------------------------------------------------

    The company plans to manufacture the listed controlled substances
in bulk for distribution to its customers.
    No comments or objections have been received. DEA has considered
the factors in 21 U.S.C. 823(a) and determined that the registration of
Cedarburg Pharmaceuticals, Inc. to manufacture the listed basic classes
of controlled substances is consistent with the public interest at this
time. DEA has investigated Cedarburg Pharmaceuticals, Inc. to ensure
that the company's registration is consistent with the public interest.
The investigation has included inspection and testing of the company's
physical security systems, verification of the company's compliance
with state and local laws, and a review of the company's background and
history. Therefore, pursuant to 21 U.S.C. 823, and in accordance with
21 CFR 1301.33(a), the above named company is granted registration as a
bulk manufacturer of the basic classes of controlled substances listed.

    Dated: March 25, 2005.
William J. Walker,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 05-6592 Filed 4-1-05; 8:45 am]

BILLING CODE 4410-09-P